Market capitalization | $878.52m |
Enterprise Value | $1.30b |
P/E (TTM) P/E ratio | 50.52 |
EV/FCF (TTM) EV/FCF | 31.98 |
EV/Sales (TTM) EV/Sales | 1.24 |
P/S ratio (TTM) P/S ratio | 0.84 |
P/B ratio (TTM) P/B ratio | 3.40 |
Dividend yield | 2.21% |
Last dividend (FY24) | $0.48 |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
5 Analysts have issued a Phibro Animal Health Corporation Class A forecast:
5 Analysts have issued a Phibro Animal Health Corporation Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,047 1,047 |
7%
7%
|
|
Gross Profit | 330 330 |
11%
11%
|
|
EBITDA | 112 112 |
2%
2%
|
EBIT (Operating Income) EBIT | 76 76 |
1%
1%
|
Net Profit | 17 17 |
16%
16%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
Head office | United States |
CEO | Jack Bendheim |
Employees | 1,940 |
Founded | 1946 |
Website | www.pahc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.